The landscape of dementia analysis has developed dramatically with the appearance of sophisticated biomarkers, including amyloid PET scans, tau imaging, and blood-centered exams which can detect Alzheimer's pathology decades just before symptoms emerge. While these technological developments characterize remarkable progress in comprehension neurode